GI/endoscopy company stock report – April 24

Here is a stock report on five publicly traded GI/endoscopy companies for April 20 to April 24.

Advertisement

•    AbbVie: $65.50 per share (up 1.95 percent)
•    Boston Scientific: $18.43 per share (up 0.05 percent)
•    FUJIFILM Holdings: $39.12 per share (down 0.27 percent)
•    Olympus: $37.87 per share (up 0.33 percent)
•    Valeant Pharmaceuticals: $209.84 per share (up 0.19 percent)

More articles on gastroenterology:
Dr. Alexandra Shustine joins SVMC Gastroenterology
Mount Sinai gastroenterologist Dr. Saul Agus dies
Where do gastroenterologists earn the most? 9 statistics

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

  • GI Partners of Illinois, the largest independent physician-led gastroenterology group in the state, has announced a strategic partnership with Nexus…

  • Colonoscopies are booming, but the economics are getting complicated.  As colorectal cancer rates climb and updated screening guidelines add millions…

Advertisement

Comments are closed.